This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Collagen And HA-Based Biomaterials 2013-2018 - Global Strategic Business Report - Review Of Major Segments

DUBLIN, April 10, 2013 /PRNewswire/ --

Research and Markets has announced the addition of the "Collagen and HA-Based Biomaterials - Global Strategic Business Report" report to their offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

This report analyzes the worldwide markets for Collagen and HA-Based Biomaterials in US$ million by the following Classification based on Application Areas: Collagen Based Biomaterials (Urinary Incontinence, Corneal Shields, Facial Aesthetic Dermal Fillers, & Wound Dressings), and Hyaluronic Acid Based Biomaterials (Viscosupplements, Viscoelastics, & Facial Aesthetic Dermal Implants).

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 63 companies including many key and niche players such as ABBOTT, Alcon Laboratories, Inc., Allergan, Inc., Anika Therapeutics, Inc., Bausch & Lomb, Inc., Lifecore Biomedical, LLC, Q-Med AB, Sanofi SA, Genzyme, Seikagaku Corp., and Teijin Pharma Limited.

Key Topics Covered: I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS II. Executive Summary

1. GLOBAL MARKET OVERVIEW 2. MARKET TRENDS AND ISSUES 3. BIOMATERIALS - A BRIEF OVERVIEW 4. SEGMENT OVERVIEW 5. PRODUCT INTRODUCTIONS/INNOVATIONS 6. RECENT INDUSTRY ACTIVITY 7. CORPORATE ACTIVITY IN THE RECENT PAST - A PERSPECTIVE BUILDER 8. FOCUS ON SELECT KEY PLAYERS 9. GLOBAL MARKET PERSPECTIVE

III. MARKET

1. THE UNITED STATES 2. CANADA 3. JAPAN 4. EUROPE 5. REST OF WORLD

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 63 (including Divisions/Subsidiaries - 69)

  • The United States (44)
  • Canada (2)
  • Japan (3)
  • Europe (18)
  • - France (1)
  • - Germany (3)
  • - The United Kingdom (5)
  • - Italy (1)
  • - Rest of Europe (8)
  • Asia-Pacific (Excluding Japan) (1)
  • Middle-East (1)

For more information visit http://www.researchandmarkets.com/research/gpks9n/collagen_and

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs